Literature DB >> 27176766

T-box transcription factor brachyury promotes tumor cell invasion and metastasis in non-small cell lung cancer via upregulation of matrix metalloproteinase 12.

Zongmiao Wan1, Dongjie Jiang1, Su Chen1, Jian Jiao1, Lei Ji2, Abdus Saboor Shah2, Haifeng Wei1, Xinghai Yang1, Xiaotao Li2, Ying Wang3, Jianru Xiao1.   

Abstract

T-box transcription factor brachyury and matrix metalloproteinases (MMPs) play important roles in non-small cell lung cancer (NSCLC) cell invasion and metastasis. However, the association between Brachyury and the MMP family has not yet been fully investigated. The present study aimed to assess the influence of Brachyury on the expression of 23 MMP members and to further explore the mechanisms involved in the promotion of NSCLC cell invasion by Brachyury and MMPs in the H460 and H1299 stable cell lines. The protein expression levels and correlations between the brachyury transcription factor and the targeted MMPs were also validated in 52 NSCLC patient tissue samples. We observed that brachyury significantly upregulated MMP12 expression to promote NSCLC cell invasion. We also found a potential binding site for the brachyury transcription factor in the MMP12 promoter.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27176766     DOI: 10.3892/or.2016.4792

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  TBX1 functions as a putative oncogene of breast cancer through promoting cell cycle progression.

Authors:  Shuya Huang; Xiang Shu; Jie Ping; Jie Wu; Jifeng Wang; Chris Shidal; Xingyi Guo; Joshua A Bauer; Jirong Long; Xiao-Ou Shu; Wei Zheng; Qiuyin Cai
Journal:  Carcinogenesis       Date:  2022-02-11       Impact factor: 4.944

2.  The embryonic transcription factor Brachyury confers chordoma chemoresistance via upregulating CA9.

Authors:  Jiao Jian; Nanzhe Zhong; Dongjie Jiang; Lei Li; Yan Lou; Wang Zhou; Su Chen; Jianru Xiao
Journal:  Am J Transl Res       Date:  2018-03-15       Impact factor: 4.060

3.  Multiple malignant tumors in a patient with familial chordoma, a case report.

Authors:  Nuttavut Sumransub; Paari Murugan; Shelly Marette; Denis R Clohisy; Keith M Skubitz
Journal:  BMC Med Genomics       Date:  2021-08-31       Impact factor: 3.063

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.